Paradigms and paradoxes of left ventricular hypertrophy: From the research laboratory to the clinical consultation;Paradigmas y paradojas de la hipertrofia ventricular izquierda: Desde el laboratorio de investigación a la consulta clínica

Archivos de Cardiologia de Mexico

Volumn 77, Issue 3, 2007, Pages 237-248

  Escudero, Eduardo Manuel ^a,b   Pinilla, Oscar Andrés ^a  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b NONE   (Argentina)

Author keywords

Left ventricular function; Left ventricular hypertrophy; Physiological hypertrophy

Indexed keywords

HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART WORK; HISTOPATHOLOGY; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

ANIMALS; BIOMEDICAL RESEARCH; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; VENTRICULAR FUNCTION, LEFT;

EID: 35348828083     PISSN: 14059940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. FREY N, OLSON EN: Cardiac hypertrophy: the good, the bad and the ugly. Annu Rev Physiol 2003; 65: 45-79.
2. RUSSEL B, MOTLAGH D, ASHLEY WW: Form follows function: How muscle shape is regulated by work. J Appl Physiol 2000; 88: 1127-1132.
3. SADOSHIMA J, IZUMO S : The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 1997; 59: 551-571
4. URBANEK K, QUAINI F, TASCA G, TORELLA D, CASTALDO C, NADAL-GINARD B, ET AL: Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 2003; 100(18): 10440-10445.
5. DEVEREUX RB, SAVAGE DD, DRAYER JIN, LARAGH JH: Left ventricular hypertrophy and function in high-, normal-, and low-renin forms of essential hypertension. Hypertension 1982; 4: 524-531.
6. DEVEREUX RB, LUTAS EM, CASALE PN, KLIGFIELD P, EISENBERG RR, HAMMOND IW, ET AL: Standarization of M-Mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984; 4: 1222-1230.
7. LEVY D, ANDERSON KM, PLEHN J, SAVAGE DD, CHRISTIANSEN JC, CASTELLI WP: Echocardiographically determined left ventricular structural and functional correlates of complex or frequent ventricular arrhythmias on one-hour ambulatory electrocardiographic monitoring. Am J Cardiol. 1987; 59(8): 836-840.
8. LEVY D, SAVAGE DD, GARRISON RJ, ANDERSON KM, KANNEL WB, CASTELLI WP: Echocardiographic criteria for left ventricular hypertrophy: The Framingham heart study. Am J Cardiol 1987; 59: 956-960.
9. KOREN MJ, DEVEREUX RB, CASALE PN, SAVAGE DD, LARAGH JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114(5): 345-352.
10. GANAU A, DEVEREUX RB, ROMAN MJ, DE SIMONE G, PICKERING TG, SABA PS, ET AL: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-1558.
11. MARCUS R, KRAUSE L, WEDER AB, DOMINGUEZ-MEJA A, SCHORK NJ, JULIUS S: Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 1994; 90(2): 928-936.
12. LIAO Y, COOPER RS, MCGEE DL, MENSAH GA, GHALI JK: The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA 1995; 273: 1592-1597.
13. JARZEMBOWSKI TM, JANICKI PK, SUKERNIK MR: Presence of concentric left ventricular remodeling and concentric left ventricular hypertrophy are associated with increased intraoperative fluid administration during large bowel surgery. Anesthesiology 2005; 103: A446.
14. LANG RM, BIERIG M, DEVEREUX RB, FLACHSKAMPF FA, FOSTER E, PELLIKKA PA, ET AL: Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18(12): 1440-1463.
15. ESCUDERO EM, DE LENA S, CINGOLANI HE: Estructura y función del ventrículo izquierdo enjóvenes estudiantes varones de la Universidad Nacional de La Plata con hipertensión arterial en estadio I. Medicina 1997; 57: 181-190.
16. ESCUDERO EM, DE LENA S, GRAFF- IVERSEN S, ALMIRON M, CINGOLANI HE: Left ventricular diastolic function in young men with high normal blood pressure. Can J Cardiol 1996; 10: 959-964.
17. DEVEREUX RB, REICHEK N: Echocardiographic determinations of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613-618.
18. YAMAZAKI T, KOMURO I, YAZAKI Y: Role of the rennin - angiotensin system in cardiac hypertrophy. Am J Cardiol 1999; 83: 53H-57H.
19. GARCIARENA CD, ENNIS IL, ESCUDERO EM, PÉREZ NG, CINGOLANI HE: La regresión de la hipertrofia cardíaca inducida por inhibición del NHE-1 se acompaña de disminución de la expresión de calcineurina Aβ. Medicina 2005; 65(Supl. II): 181-182.
20. ENNIS IL, ESCUDERO EM, PÉREZ NG, CAMILIÓN DE HURTADO MC, CINGOLANI HE: Regression of isoproterenol induced myocardial hypertrophy by Na+/H+ exchanger inhibition. Hypertension 2003; 41(6): 1324-1329.
21. AIELLO EA, VILLA-ABRILLE MC, ESCUDERO EM, PORTIANSKY EL, PÉREZ NG, CAMILION DE HURTADO MC, ET AL: Myocardial hypertrophy of normotensive Wistar-Kyoto rats. Am J Physiol Heart Circ Physiol 2004; 286: H1229-H1235.
22. PÉREZ NG, ESCUDERO EM, PORTIANSKI EL, CAMILIÓN DE HURTADO MC, CINGOLANI HE. Regression and prevention of hypertrophy and fibrosis by Na+/H+ exchange inhibition. J Mol Cell Cardiol 2002; 34: A 17.
23. + exchanger blockade and protection against myocardial Infarction. Hypertension. 2007; 49: 1095-1103.
24. CINGOLANI HE, REBOLLEDO OR, PORTIANSKY EL, PÉREZ NG, CAMILIÓN DE HURTADO MC. Regression of hypertensive myocardial fibrosis by Na+/H+ exchange inhibition. Hypertension 2003; 41(2): 373-377.
25. ESCUDERO EM, TUFARE AL, REBOLLEDO O, PELLEGRINI L, LOBRUTTO C: Serum carboxyl-terminal propeptide of procollagen type I in exercise-induced left ventricular hypertrophy. Clin Cardiol 2004; 27(8): 471-474.
26. KANNEL WB, DAUENBERG AL, LEVY D: Population implications of electrocardiographic left ventricular hypertrophy. Am. J Cardiol 1987; 60: 851-931.
27. LEVY D, GARRISON RJ, SAVAGE DD: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
28. LEVY D, SALOMON M, D'AGOSTINO RB, BELANGER AJ, KANNEL WB: Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation, 1994; 90: 1786-1793.
29. CASALE PN, DEVEREUX RB, MILNER M, ZULIO G, HARSHFIELD GA, PICKERING TG, ET AL: Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Arch Intem Med 1986; 105: 173-178.
30. SCHILLACI G, VERDECCHIA P, PORCELLATI C, CUCCURULLO O, COSCO C, PERTICONE F: Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: 580-586.
31. BROWN DW, GILES WH, CROFT JB. Left ventricular hypertrophy as a predictor of Coronary Heart Disease Mortality and the effect of hypertension. Am Heart J 2000; 14: 848-856.
32. EAST MA, JOLLIS JG, NELSON CL, MARKS D, PETERSON ED: The influence of left ventricular hypertrophy on survival in patients with coronary artery disease: Do race and gender matter? J Am Coll Cardiol 2003; 41: 949-954.
33. GHALI JK, LIAO Y, COOPER RS: Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol 1998; 31: 1635-1640.
34. PALMON LC, REICHEK N, YEON SB, CLARK NR, BROWNSON D, HOFFMAN E, ET AL: Intramural myo cardial shortening in hypertensive left ventricular hypertrophy with normal pump function. Circulation 1994; 89(1): 122-31.
35. LUTAS EM, DEVEREUX RB, REIS G, ALDERMAN MH, PICKERING TG, BORER JS, ET AL: Increased cardiac performance in mild essential hypertension: left ventricular mechanics. Hypertension 1985; 7: 979-988.
36. SHIMUZU G, HIROTA Y, KITA Y, KAWAMURA K, SAITO T, GAASCH WH: Left ventricular midwall mechanics in systemic arterial hypertension: myocardial function is depressed in pressure-overload hypertrophy. Circulation 1991; 83: 1676-1684.
37. DEVEREUX RB, ROMAN MJ, PALMIERI V, OKIN PM, BOMAN K, GERDTS E, ET AL: Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study. J Hypertension 2000; 18: 1129-1138.
38. AURIGEMMA GP, SILVER KH, FOX MA, GAASCH WH: Depressed midwall and long axis shortening in hypertensive left ventricular hypertrophy with normal ejection fraction. J Am Coll Cardiol 1995; 26: 195-202.
39. ESCUDERO EM, TUFARE AL, ENNIS IL, GARCIARENA CD, PINILLA OA, CARRANZA VB: Análisis ecocardiográfico del efecto de diferentes inhibidores del intercambiador Na+/H+ sobre la estructura y función sistólica del ventrículo izquierdo en ratas espontáneamente hipertensas. Medicina 2006; 66: 392-398.
40. D'HOOGE J, HEIMDAL A, JAMAL F, KUKULSKI T, BIJNENS B, RADEMAKERS F, ET AL: Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr 2000; 1(3): 154-170.
41. TUFARE AL, ESCUERO EM, ANKUDOWICZ V: Deterioro temprano de la contractilidad en la hipertrofia secundaria a hipertensión. Revista FAC 2005; 34 (Supl. II): 53.
42. PÉREZ NG, HASHIMOTO K, MCCUNE S, ALTSCHULD RA, MARBÁN E: Origin of contractile dysfunction in heart failure: calcium cycling versus myofilaments. Circulation 1999; 99: 1077-1083.
43. MOLKENTIN JD, LU JR, ANTOS CL, MARKHAM B, RICHARDSON J, ROBBINS J, ET AL: A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998; 93: 215-228.
44. CINGOLANI OH, YANG X-P, CAVASIN MA, CARRETERO OA: Increased systolic performance with diastolic dysfunction in adult spontaneously hypertensive rats. Hypertension 2003; 41(2): 249-254.
45. VASAN RS, BENJAMIN EJ, LEVY D: Congestive heart failure with normal left ventricular systolic function. Clinical approaches to the diagnosis and treatment of diastolic heart failure. Arch Intern Med 1996; 156(2): 146-157.
46. MANDINOV L, EBERLI FR, SEILER C, HESS OM: Diastolic Heart Failure. Cardiovasc Res 2000; 45(4): 813-825.
47. TUFARE AL, ESCUDERO EM, CAMILIÓN DE HURTADO MC: Hipertrofia ventricular izquierda y progresión a la insuficiencia cardíaca en ratas espontáneamente hipertensas. XI Congreso Argentino de Hipertensión Arterial. 6-9 de Mayo 2004, Buenos Aires, Argentina.
48. MATSUI H, MACLENNAN DH, ALPERT NR, PERIASAMY M: Sarcoplasmic reticulum gene expression in pressure overload-induced cardiac hypertrophy in rabbit. Am J Physiol 1995; 268 (1 Pt 1): C252-258.
49. WILLIAMS RS: Apoptosis and Heart Failure. N Engl J Med 1999; 341(10): 759-760.
50. AHMED SH, CLARK LL, PENNINGTON WR, WEBB CS, BONNEMA DD, LEONARDI AH, ET AL: Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 2006; 113(17): 2089-2096.